Skip to content
HowShorted

ADIAL PHARMACEUTICALS, INC. short interest in 2020

In 2020, ADIAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 1.40% of shares outstanding on 15 Jan 2020 to 2.24% on 31 Dec 2020, a change of +0.84 percentage points. The year's high was 4.67% on 30 Oct 2020 and its low 0.04% on 30 Apr 2020, averaging 1.84% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.73 days on 15 Jan 2020. Full history: ADIAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ADIAL PHARMACEUTICALS, INC. in 2020

2020 in figures

Start of year
1.40% (15 Jan 2020)
End of year
2.24% (31 Dec 2020)
Change
+0.84 pp
High
4.67% (30 Oct 2020)
Low
0.04% (30 Apr 2020)
Average
1.84%
Highest days to cover
2.73 (15 Jan 2020)
SEC filings marked
4

Every report in 2020

ADIAL PHARMACEUTICALS, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20201.40%2.73
31 Jan 20200.62%1.31
14 Feb 20200.37%1.00
28 Feb 20200.28%1.00
13 Mar 20200.40%1.00
31 Mar 20200.12%1.0010-K filed
15 Apr 20200.08%1.00
30 Apr 20200.04%1.00
15 May 20200.04%1.0010-Q filed
29 May 20200.08%1.00
14 Aug 20201.92%1.0010-Q filed
31 Aug 20203.80%1.04
15 Sep 20204.14%1.61
30 Sep 20204.54%1.00
15 Oct 20204.12%1.00
30 Oct 20204.67%1.00
13 Nov 20202.99%1.0410-Q filed
30 Nov 20202.56%1.00
15 Dec 20202.37%1.00
31 Dec 20202.24%1.31

See also: ADIAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.